Nodal Marginal Zone Lymphoma: What Do We Really Know? Cancer Network For example, the RESORT trial,[2] which addressed the question of maintenance rituximab vs retreatment rituximab, was designed statistically to test the question in patients with follicular lymphoma (a more common entity). In addition, patients with ... |
